Emerging role of GLP-1 receptor agonists in the treatment of obesity
Lisa M Neff1, Robert F Kushner21Division of Endocrinology, Metabolism, and Molecular Medicine, 2Division of General Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USAAbstract: The prevalence of obesity has increased dramatically in recent decades,...
Main Authors: | Lisa M Neff, Robert F Kushner |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-07-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Online Access: | http://www.dovepress.com/emerging-role-of-glp-1-receptor-agonists-in-the-treatment-of-obesity-a4877 |
Similar Items
-
Emerging role of GLP-1 receptor agonists in the treatment of obesity
by: Neff LM
Published: (2010-07-01) -
GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
by: Jing-Yue Wang, et al.
Published: (2023-02-01) -
GLP-1 agonists in treatment of obesity
by: Władysław Orłowski, et al.
Published: (2023-01-01) -
Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
by: Marta Seghieri, et al.
Published: (2018-11-01) -
GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes
by: Sydney S. Wilbon, et al.
Published: (2023-12-01)